z-logo
open-access-imgOpen Access
Leveraging Telemedicine for Chronic Disease Management in Low- and Middle-Income Countries During Covid-19
Author(s) -
Michael A. Hoffer-Hawlik,
Andrew E. Moran,
Daniel Burka,
Prabhdeep Kaur,
Jun Cai,
Thomas R. Frieden,
Reena Gupta
Publication year - 2020
Publication title -
global heart
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 37
eISSN - 2211-8179
pISSN - 2211-8160
DOI - 10.5334/gh.852
Subject(s) - telemedicine , medicine , pandemic , covid-19 , health care , developing country , disease management , low and middle income countries , medical emergency , chronic disease , disease , family medicine , economic growth , infectious disease (medical specialty) , pathology , parkinson's disease , economics
In response to the Covid-19 pandemic, many low- and middle-income countries (LMICs) expanded access to telemedicine to maintain essential health services. Although there has been attention to the accelerated growth of telemedicine in the United States and other high-income countries, the telemedicine revolution may have an even greater benefit in LMICs, where it could improve health care access for vulnerable and geographically remote patients. In this article, we survey the expansion of telemedicine for chronic disease management in LMICs and describe seven key steps needed to implement telemedicine in LMIC settings. Telemedicine can not only maintain essential medical care for chronic disease patients in LMICs throughout the Covid-19 pandemic, but also strengthen primary health care delivery and reduce socio-economic disparities in health care access over the long-term.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom